Svetlana(Primma)EckertMD

Neuroimmunology/Multiple Sclerosis

UBMD Neurology

Dr. Eckert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University at BuffaloFellowship, Neuroimmunology & Multiple Sclerosis, 2017 - 2019
University at BuffaloResidency, Neurology, 2013 - 2017
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2013

PubMed

19 citations
COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections.
Dejan Jakimovski, Karen Zakalik, Samreen Awan, Katelyn S Kavak, Penny Pennington
Vaccines. 2022-04-28
15 citations
Long-term drug treatment in multiple sclerosis: safety success and concerns.
Dejan Jakimovski, Caila B. Vaughn, Svetlana Eckert, Robert Zivadinov, Bianca Weinstock-Guttman
Expert Opinion on Drug Safety. 2020-08-13
12 citations
Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis
Emanuele Ghione, Niels Bergsland, Michael G. Dwyer, Jesper Hagemeier, Dejan Jakimovski
AJNR. American Journal of Neuroradiology. 2020-08-06

Role of Evusheld in Preventing COVID Infections in Multiple SclerosisMarch 6th, 2023
Evusheld for Prevention of COVID Infection in Multiple SclerosisMarch 6th, 2023
‘Usual Suspect’ Lesions Appear Not to Cause Most Severe Disability in Multiple Sclerosis PatientsFebruary 25th, 2023
Join now to see all